213 related articles for article (PubMed ID: 9637557)
1. Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities.
Fuhrman GM; Cederbom GJ; Bolton JS; King TA; Duncan JL; Champaign JL; Smetherman DH; Farr GH; Kuske RR; McKinnon WM
Ann Surg; 1998 Jun; 227(6):932-9. PubMed ID: 9637557
[TBL] [Abstract][Full Text] [Related]
2. Benign diagnosis by image-guided core-needle breast biopsy.
Duncan JL; Cederbom GJ; Champaign JL; Smetherman DH; King TA; Farr GH; Waring AN; Bolton JS; Fuhrman GM
Am Surg; 2000 Jan; 66(1):5-9; discussion 9-10. PubMed ID: 10651339
[TBL] [Abstract][Full Text] [Related]
3. Biopsy technique has no impact on local recurrence after breast-conserving therapy.
King TA; Hayes DH; Cederbom GJ; Champaign JL; Smetherman DH; Farr GH; Bolton JS; Fuhrman GM
Breast J; 2001; 7(1):19-24. PubMed ID: 11348411
[TBL] [Abstract][Full Text] [Related]
4. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
[TBL] [Abstract][Full Text] [Related]
5. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities.
White RR; Halperin TJ; Olson JA; Soo MS; Bentley RC; Seigler HF
Ann Surg; 2001 Jun; 233(6):769-77. PubMed ID: 11371735
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.
Fuhrman G; Cederbom G; Champagne J; Farr G; McKinnon W; Bolton J; Ordoyne WK
J La State Med Soc; 1996 Apr; 148(4):167-70. PubMed ID: 8935619
[TBL] [Abstract][Full Text] [Related]
7. The contribution of cytologic imprints of stereotactically guided core needle biopsies of the breast in the management of patients with mammographic abnormalities.
Green RS; Mathew S
Breast J; 2001; 7(4):214-8. PubMed ID: 11678797
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation.
Verkooijen HM;
Int J Cancer; 2002 Jun; 99(6):853-9. PubMed ID: 12115488
[TBL] [Abstract][Full Text] [Related]
9. A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning.
King TA; Cederbom GJ; Champaign JL; Smetherman DH; Bolton JS; Farr GH; McKinnon WM; Kuske RR; Fuhrman GM
Am J Surg; 1998 Dec; 176(6):497-501. PubMed ID: 9926778
[TBL] [Abstract][Full Text] [Related]
10. Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities.
Zhao L; Freimanis R; Bergman S; Shen P; Perrier ND; Lesko N; Pulaski T; Pulaski S; Carr JJ; Levine EA
Am Surg; 2003 Sep; 69(9):757-62; discussion 762. PubMed ID: 14509322
[TBL] [Abstract][Full Text] [Related]
11. The advanced breast biopsy instrumentation (ABBI) experience at a community hospital.
Sheth D; Wesen CA; Schroder D; Boccaccio JE; Lloyd LR
Am Surg; 1999 Aug; 65(8):726-9; discussion 729-30. PubMed ID: 10432081
[TBL] [Abstract][Full Text] [Related]
12. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
[TBL] [Abstract][Full Text] [Related]
13. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
14. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy.
Winchester DJ; Bernstein JR; Jeske JM; Nicholson MH; Hahn EA; Goldschmidt RA; Watkin WG; Sener SF; Bilimoria MB; Barrera E; Winchester DP
Arch Surg; 2003 Jun; 138(6):619-22; discussion 622-3. PubMed ID: 12799332
[TBL] [Abstract][Full Text] [Related]
15. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
16. Imaging-guided core needle biopsy of papillary lesions of the breast.
Rosen EL; Bentley RC; Baker JA; Soo MS
AJR Am J Roentgenol; 2002 Nov; 179(5):1185-92. PubMed ID: 12388496
[TBL] [Abstract][Full Text] [Related]
17. False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 concecutive cases of missed breast cancer.
Shah VI; Raju U; Chitale D; Deshpande V; Gregory N; Strand V
Cancer; 2003 Apr; 97(8):1824-31. PubMed ID: 12673707
[TBL] [Abstract][Full Text] [Related]
18. Atypical hyperplasia in the era of stereotactic core needle biopsy.
Brown TA; Wall JW; Christensen ED; Smith DV; Holt CA; Carter PL; Patience TH; Babu SS; Williard WC
J Surg Oncol; 1998 Mar; 67(3):168-73. PubMed ID: 9530887
[TBL] [Abstract][Full Text] [Related]
19. Role of US-guided fine-needle aspiration with on-site cytopathologic evaluation in management of nonpalpable breast lesions.
Buchbinder SS; Gurell DS; Tarlow MM; Salvatore M; Suhrland MJ; Kader K
Acad Radiol; 2001 Apr; 8(4):322-7. PubMed ID: 11293780
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.
Jackman RJ; Nowels KW; Rodriguez-Soto J; Marzoni FA; Finkelstein SI; Shepard MJ
Radiology; 1999 Mar; 210(3):799-805. PubMed ID: 10207484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
